Related Experiment Videos
X-linked recessive disorders: chronic granulomatous disease and Wiskott-Aldrich syndrome
The Journal of Investigative Dermatology
|June 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2004
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2002
Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2002
Artificial Intelligence Techniques for Diagnosing and Quantifying Vitiligo: A Systematic Review and Meta-Analysis.
The Journal of investigative dermatology·2026
TLR4 epidermal genetic deletion protects against acute and tumorigenic UV exposure in SKH-1 mouse skin.
The Journal of investigative dermatology·2026
Evidence that IL-4/IL-13-Responsive IGFLs Promote Allergic Skin Inflammation.
The Journal of investigative dermatology·2026
DNPH1 exerts context-dependent tumor-promoting and -repressing functions during melanoma development.
The Journal of investigative dermatology·2026
Skin Cancer Risk Stratification and Outcomes in Swedish Solid Organ Transplant Recipients.
The Journal of investigative dermatology·2026
Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas.
The Journal of investigative dermatology·2026